HHS awards $38.9M for CDER Business Intelligence and Publishing to Deloitte & Touche LLP

Contract Overview

Contract Amount: $38,889,552 ($38.9M)

Contractor: Deloitte & Touche LLP

Awarding Agency: Department of Health and Human Services

Start Date: 2020-05-13

End Date: 2024-06-09

Contract Duration: 1,488 days

Daily Burn Rate: $26.1K/day

Competition Type: COMPETED UNDER SAP

Number of Offers Received: 1

Pricing Type: LABOR HOURS

Sector: Other

Official Description: CDER BUSINESS INTELLIGENCE AND PUBLISHING

Place of Performance

Location: SILVER SPRING, MONTGOMERY County, MARYLAND, 20903

State: Maryland Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $38.9 million to DELOITTE & TOUCHE LLP for work described as: CDER BUSINESS INTELLIGENCE AND PUBLISHING Key points: 1. Contract awarded to a single, well-known vendor. 2. Focus on professional, scientific, and technical services. 3. Long duration suggests ongoing need. 4. Significant contract value for specialized services.

Value Assessment

Rating: fair

The contract value of $38.9M over approximately 4 years is substantial. Benchmarking against similar 'All Other Professional, Scientific, and Technical Services' contracts is difficult without more specific service details. The pricing is likely based on labor hours, which can vary.

Cost Per Unit: N/A

Competition Analysis

Competition Level: limited

The contract was competed under SAP (System for Award Management), suggesting some level of competition, but the award type 'BPA CALL' implies it might be a call against an existing Blanket Purchase Agreement, potentially limiting broader competition. The pricing discovery relies on the established BPA terms.

Taxpayer Impact: Taxpayer funds are being used for specialized business intelligence and publishing services, essential for regulatory functions. The value for money depends on the efficiency and effectiveness of the services provided.

Public Impact

Ensures critical business intelligence and publishing functions for the FDA's CDER are maintained. Supports regulatory processes and public access to information. Impacts the efficiency of drug review and approval processes.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Warning Flags

Positive Signals

Sector Analysis

This contract falls under 'All Other Professional, Scientific, and Technical Services,' a broad category. Spending benchmarks for this specific niche within the FDA are not readily available, but the value is significant for specialized support.

Small Business Impact

The data indicates this contract was not set aside for small businesses and was awarded to a large, established firm. There is no indication of small business participation in this specific award.

Oversight & Accountability

The contract was competed under SAP, suggesting a degree of oversight. However, the 'BPA CALL' nature warrants scrutiny to ensure fair pricing and continued justification for the chosen vendor over time.

Related Government Programs

Risk Flags

Tags

all-other-professional-scientific-and-te, department-of-health-and-human-services, md, bpa-call, 10m-plus

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $38.9 million to DELOITTE & TOUCHE LLP. CDER BUSINESS INTELLIGENCE AND PUBLISHING

Who is the contractor on this award?

The obligated recipient is DELOITTE & TOUCHE LLP.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Food and Drug Administration).

What is the total obligated amount?

The obligated amount is $38.9 million.

What is the period of performance?

Start: 2020-05-13. End: 2024-06-09.

What specific metrics are used to evaluate the value and effectiveness of the 'CDER BUSINESS INTELLIGENCE AND PUBLISHING' services provided by Deloitte & Touche LLP?

The provided data does not specify the metrics used for evaluating the value and effectiveness of these services. Typically, such evaluations would involve performance standards related to data accuracy, timeliness of publishing, user satisfaction, and contribution to CDER's mission objectives. A review of the contract's Statement of Work (SOW) and performance reports would be necessary to identify these metrics.

Given the limited competition, how can the FDA ensure it is receiving competitive pricing for these services over the contract's duration?

Ensuring competitive pricing with limited competition often involves robust negotiation during the initial BPA establishment and subsequent call orders. The FDA should regularly benchmark pricing against market data for similar services, conduct periodic price analyses, and potentially re-compete the BPA if market conditions or service needs change significantly. Transparency in the call order process is also crucial.

What is the potential impact on FDA operations if Deloitte & Touche LLP's services are not effectively delivered under this contract?

Ineffective delivery of business intelligence and publishing services could significantly disrupt FDA operations. This might include delays in disseminating critical drug information, hindering regulatory decision-making, impacting public access to safety data, and potentially slowing down the drug approval process. This could lead to increased costs and reduced public trust.

Industry Classification

NAICS: Professional, Scientific, and Technical ServicesOther Professional, Scientific, and Technical ServicesAll Other Professional, Scientific, and Technical Services

Product/Service Code: SUPPORT SVCS (PROF, ADMIN, MGMT)PROFESSIONAL SERVICES

Competition & Pricing

Extent Competed: COMPETED UNDER SAP

Solicitation Procedures: SIMPLIFIED ACQUISITION

Solicitation ID: 1223603

Offers Received: 1

Pricing Type: LABOR HOURS (Z)

Evaluated Preference: NONE

Contractor Details

Parent Company: Deloitte Touche Tohmatsu Limited

Address: 1919 N LYNN ST, ARLINGTON, VA, 22209

Business Categories: Category Business, Not Designated a Small Business, Partnership or Limited Liability Partnership, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $38,889,552

Exercised Options: $38,889,552

Current Obligation: $38,889,552

Actual Outlays: $28,036,716

Subaward Activity

Number of Subawards: 20

Total Subaward Amount: $3,019,734

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Parent Contract

Parent Award PIID: HHSF223201700001B

IDV Type: BPA

Timeline

Start Date: 2020-05-13

Current End Date: 2024-06-09

Potential End Date: 2024-06-09 00:00:00

Last Modified: 2023-06-06

More Contracts from Deloitte & Touche LLP

View all Deloitte & Touche LLP federal contracts →

Other Department of Health and Human Services Contracts

View all Department of Health and Human Services contracts →

Explore Related Government Spending